- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
3.—(1) Regulation 17(1) is amended as follows.
(2) In paragraph (2), for “paragraphs (3) to (5)” substitute “paragraphs (3) to (9)”.
(3) After paragraph (8) insert—
“(9) Paragraph (1)(d) does not apply to the importation of a medicinal product into Northern Ireland from Great Britain by the holder of a wholesale dealer’s licence, where the following conditions are met—
(a)the medicinal product has undergone—
(i)in an EEA State, the quality control testing provided for by Article 51 of the 2001 Directive, or
(ii)in the United Kingdom, checks in accordance with these Regulations and the requirements of the marketing authorisation relating to the product and that these are appropriately certified;
(b)the batch release of the medicinal product has been undertaken—
(i)in Northern Ireland or an EEA State, by a qualified person in accordance with Article 51(1) of the 2001 Directive, and it is accompanied by the appropriate control reports, or
(ii)in Great Britain, by a qualified person applying equivalent standards;
(c)the medicinal product has a UKMA(UK) or UKMA(NI);
(d)the importation of the medicinal product is with a view to its sale or supply in Northern Ireland only; and
(e)in the case of medicinal products, other than radiopharmaceuticals, that are required to bear safety features pursuant to Article 54a of the 2001 Directive, that the features specified in paragraph 18A of Schedule 24 are affixed on the packaging.”.
Regulation 17 was amended by S.I. 2019/775, as amended by S.I. 2020/1488.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: